Published in Eur Heart J on August 30, 2013
Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT (METS) | NCT02968771
Development of Novel Physiological CMR Methods in Health and Disease | NCT03854071
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70
Ranolazine: A Contemporary Review. J Am Heart Assoc (2016) 3.67
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Sci Transl Med (2016) 2.69
Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With Coronary Disease. J Am Coll Cardiol (2016) 1.66
Relationships between myocardial perfusion abnormalities and poststress left ventricular functional impairment on cadmium-zinc-telluride imaging. Eur J Nucl Med Mol Imaging (2015) 1.44
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J (2016) 1.42
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). JACC Heart Fail (2014) 1.41
Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA (2014) 1.17
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document. Orphanet J Rare Dis (2015) 1.04
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J (2014) 1.04
Biomechanical factors in atherosclerosis: mechanisms and clinical implications. Eur Heart J (2014) 1.03
Treatment variation in stent choice in patients with stable or unstable coronary artery disease. Neth Heart J (2016) 1.02
The Western Denmark Cardiac Computed Tomography Registry: a review and validation study. Clin Epidemiol (2014) 0.98
Catheter-based functional metrics of the coronary circulation. J Nucl Cardiol (2016) 0.96
Rationale and design of the Measuring Athlete's Risk of Cardiovascular events (MARC) study : The role of coronary CT in the cardiovascular evaluation of middle-aged sportsmen. Neth Heart J (2015) 0.96
Coronary revascularization in the elderly with stable angina. J Geriatr Cardiol (2015) 0.93
Fractional flow reserve derived from coronary CT angiography in stable coronary disease: a new standard in non-invasive testing? Eur Radiol (2015) 0.91
Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification. Front Physiol (2014) 0.89
Peripheral arterial tonometry cannot detect patients at low risk of coronary artery disease. Neth Heart J (2015) 0.88
The influence of a ten-week Nordic walking training-rehabilitation program on the level of lipids in blood in overweight and obese postmenopausal women. J Phys Ther Sci (2015) 0.88
Cardiac CT: atherosclerosis to acute coronary syndrome. Cardiovasc Diagn Ther (2014) 0.88
Cardiac CT vs. Stress Testing in Patients with Suspected Coronary Artery Disease: Review and Expert Recommendations. Curr Cardiovasc Imaging Rep (2015) 0.87
Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress. Antioxid Redox Signal (2015) 0.86
Management standards for stable coronary artery disease in India. Indian Heart J (2016) 0.86
Practice Patterns for Outpatients With Stable Coronary Artery Disease: A Case Vignette-based Survey Among French Cardiologists. EBioMedicine (2015) 0.86
Impact of Clinical Guideline Recommendations on the Application of Coronary Computed Tomographic Angiography in Patients with Suspected Stable Coronary Artery Disease. Chin Med J (Engl) (2016) 0.85
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. Eur Heart J (2015) 0.85
Different Plaque Composition and Progression in Patients with Stable and Unstable Coronary Syndromes Evaluated by Cardiac CT. Biomed Res Int (2015) 0.84
Incremental cost-effectiveness of dobutamine stress cardiac magnetic resonance imaging in patients at intermediate risk for coronary artery disease. Clin Res Cardiol (2014) 0.84
Diagnosis and management of ischemic cardiomyopathy: Role of cardiovascular magnetic resonance imaging. World J Cardiol (2014) 0.84
Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the "suspected CAD" cohort of the european cardiovascular magnetic resonance registry. J Cardiovasc Magn Reson (2016) 0.84
NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice. Eur Heart J (2015) 0.84
Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial. Circ Cardiovasc Interv (2016) 0.84
Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. J Cardiovasc Magn Reson (2016) 0.83
Reliability of a new method for coronary artery calcium or metal subtraction by 320-row cardiac CT. Eur Radiol (2015) 0.83
Analyses of drugs stored at home by elderly patients with chronic heart failure. Clin Res Cardiol (2014) 0.83
Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction: recent developments. Eur Heart J (2015) 0.83
Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes. Quant Imaging Med Surg (2014) 0.83
Cardiac computed tomography in patients with acute chest pain. Eur Heart J (2015) 0.83
Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease. J Am Coll Cardiol (2016) 0.83
Differences in the clinical effects of angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers: a critical review of the evidence. Am J Cardiovasc Drugs (2014) 0.82
Intentional right atrial exit for microcatheter infusion of pericardial carbon dioxide or iodinated contrast to facilitate sub-xiphoid access. Catheter Cardiovasc Interv (2014) 0.82
Chronic total occlusion: To treat or not to treat. World J Cardiol (2014) 0.82
[Chronic chest pain]. Schmerz (2014) 0.81
Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study. Clin Cardiol (2015) 0.81
Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania. Clin Interv Aging (2015) 0.81
Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment. J Geriatr Cardiol (2016) 0.81
The prognostic role of stress echocardiography in a contemporary population and the clinical significance of limited apical ischaemia. Echo Res Pract (2016) 0.80
Use of exercise tests in primary care: importance for referral decisions and possible bias in the decision process; a prospective observational study. BMC Fam Pract (2014) 0.80
Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial. J Med Internet Res (2015) 0.80
Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review. Cardiovasc Ther (2016) 0.80
Effects of moderate aerobic exercise training on hemorheological and laboratory parameters in ischemic heart disease patients. PLoS One (2014) 0.80
Coronary procedures in German hospitals: a detailed analysis for specific patient clusters. Clin Res Cardiol (2015) 0.80
Myocardial perfusion SPECT 2015 in Germany. Results of the 7th survey. Nuklearmedizin (2016) 0.80
The Differential Diagnosis of Dyspnea. Dtsch Arztebl Int (2016) 0.79
Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era. Scientifica (Cairo) (2016) 0.79
Visualization of endothelial barrier damage prior to formation of atherosclerotic plaques. Histochem Cell Biol (2017) 0.79
Risk prediction with triglycerides in patients with stable coronary disease on statin treatment. Clin Res Cardiol (2014) 0.79
Gender differences in health-related quality of life in patients undergoing coronary angiography. Open Heart (2015) 0.79
Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease. J Cardiovasc Magn Reson (2014) 0.79
Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. Eur Heart J Cardiovasc Imaging (2015) 0.79
Complex networks approach for analyzing the correlation of traditional chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease. Evid Based Complement Alternat Med (2015) 0.79
Diagnostic Strategies for the Evaluation of Chest Pain: Clinical Implications From SCOT-HEART and PROMISE. J Am Coll Cardiol (2016) 0.79
The Impact of Fractional Flow Reserve on Revascularization. Cardiol Ther (2015) 0.79
Assessment of left anterior descending artery stenosis of intermediate severity by fractional flow reserve, instantaneous wave-free ratio, and non-invasive coronary flow reserve. Int J Cardiovasc Imaging (2016) 0.78
Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival. Curr Opin Organ Transplant (2016) 0.78
ST-segment changes in high-resolution body surface potential maps measured during exercise to assess myocardial ischemia: a pilot study. Arch Med Sci (2014) 0.78
Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study. Eur J Clin Pharmacol (2015) 0.78
Multi-modality imaging for the assessment of myocardial perfusion with emphasis on stress perfusion CT and MR imaging. Int J Cardiovasc Imaging (2015) 0.78
Efficacy of Patient Selection for Diagnostic Coronary Angiography in Suspected Coronary Artery Disease. Arq Bras Cardiol (2015) 0.78
Cytomegalovirus-Productive Infection Is Associated With Acute Coronary Syndrome. J Am Heart Assoc (2016) 0.78
Single bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla. J Cardiovasc Magn Reson (2015) 0.78
Angina treatments and prevention of cardiac events: an appraisal of the evidence. Eur Heart J Suppl (2015) 0.78
Duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of large randomised controlled trials. Sci Rep (2015) 0.78
Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections. Clin Res Cardiol (2014) 0.78
Feasibility and safety of adenosine cardiovascular magnetic resonance in patients with MR conditional pacemaker systems at 1.5 Tesla. J Cardiovasc Magn Reson (2015) 0.78
Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease. Cardiovasc Ultrasound (2017) 0.78
Myocardial ischemia in the absence of obstructive coronary lesion: The role of post-stress diastolic dysfunction in detecting early coronary atherosclerosis. J Nucl Cardiol (2016) 0.77
Comparison of standard- and high-dose intracoronary adenosine for the measurement of coronary fractional flow reserve (FFR). Clin Res Cardiol (2016) 0.77
The Updated NICE Guidelines: Cardiac CT as the First-Line Test for Coronary Artery Disease. Curr Cardiovasc Imaging Rep (2017) 0.77
Biodistribution and radiation dosimetry of (82)Rb at rest and during peak pharmacological stress in patients referred for myocardial perfusion imaging. Eur J Nucl Med Mol Imaging (2015) 0.77
Danish study of Non-Invasive testing in Coronary Artery Disease (Dan-NICAD): study protocol for a randomised controlled trial. Trials (2016) 0.77
Sequential activation of different pathway networks in ischemia-affected and non-affected myocardium, inducing intrinsic remote conditioning to prevent left ventricular remodeling. Sci Rep (2017) 0.77
Outcomes of percutaneous coronary intervention in patients ≥ 75 years: one-center study in a Chinese patient group. J Geriatr Cardiol (2015) 0.77
Impaired Coronary and Renal Vascular Function in Spontaneously Type 2 Diabetic Leptin-Deficient Mice. PLoS One (2015) 0.77
Off-pump coronary artery bypass grafting versus optimal medical therapy alone: effectiveness of incomplete revascularization in high risk patients. J Geriatr Cardiol (2016) 0.77
Impairment of aspirin antiplatelet effects by non-opioid analgesic medication. World J Cardiol (2015) 0.77
Medical management of chronic stable angina. Aust Prescr (2015) 0.77
Utility of both carotid intima-media thickness and endothelial function for cardiovascular risk stratification in patients with angina-like symptoms. Int J Cardiol (2015) 0.77
Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study. J Am Heart Assoc (2016) 0.77
Likelihood of myocardial infarction during stroke rehabilitation preceded by cardiovascular screening and an exercise tolerance test: the Locomotor Experience Applied Post-Stroke (LEAPS) trial. Int J Stroke (2014) 0.77
Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy. Nat Rev Cardiol (2015) 0.77
Drivers of the Sex Disparity in Statin Therapy in Patients with Coronary Artery Disease: A Cohort Study. PLoS One (2016) 0.77
Fractional flow reserve guided revascularization in daily practice: clinical judgment does not always meet science. Cardiovasc Diagn Ther (2013) 0.77
Telomere length, antioxidant status and incidence of ischaemic heart disease in type 2 diabetes. Int J Cardiol (2016) 0.77
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2012) 18.18
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2009) 18.03
Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation (2006) 11.78
Universal definition of myocardial infarction. Circulation (2007) 11.69
Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med (2013) 11.14
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70